Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapyKazuho Miyashita, Yoshiaki Ishigatsubo, Takuya Miyazaki et al.|Leukemia Research|2015Cited by 35
Prognostic significance of serum beta-2 microglobulin level in Hodgkin lymphoma treated with ABVD-based therapyYuki Nakajima, Yoshiaki Ishigatsubo, Naoto Tomita et al.|Medical Oncology|2014Cited by 15
A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-Host Disease by National Institutes of Health Criteria in a Japanese CohortChikako Ohwada, Shinichiro Okamoto, Emiko Sakaida et al.|Transplantation and Cellular Therapy|2019Cited by 13
Predictive values of early suppression of tumorigenicity 2 for acute GVHD and transplant-related complications after allogeneic stem cell transplantation: prospective observational studyAyako Matsumura, Hideaki Nakajima, Takuya Miyazaki et al.|Turkish Journal of Hematology|2019Cited by 10
Successful pregnancy and delivery via in vitro fertilization with cryopreserved and thawed embryo transfer in an acute myeloid leukemia patient after allogeneic bone marrow transplantationYuki Nakajima, Shin Fujisawa, Hideyuki Kuwabara et al.|International Journal of Hematology|2014Cited by 9